Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

13.45 +0.39 (+2.99%)
Delayed Quote Updated: 2:10 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
Bioventus (BVS) Q2 2026 Earnings Call Transcript ↗
Pain Treatments surged 11.5% as management explores strategic alternatives. 
Via The Motley Fool
Topics Earnings
News headline image
Bioventus Q2 Earnings Call Highlights ↗
Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt... 
Via MarketBeat
Topics Earnings
Bioventus (NASDAQ:BVS) Falls After Q2 Revenue Miss, Launches Strategic Review ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally ↗
Via Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls ↗
Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Bioventus (BVS) Q1 2026 Earnings Transcript ↗
Bioventus (BVS) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: Bioventus's Earnings Outlook ↗
 
Via Benzinga
News headline image
Bioventus (BVS) Q4 2025 Earnings Call Transcript ↗
Bioventus (BVS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
These stocks are gapping in today's session ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth ↗
Bioventus (BVS) reported strong Q3 2025 earnings, beating EPS estimates with a 200% surge. While revenue slightly missed, organic growth was up 8.2%. 
Via Chartmill
Topics Earnings
News headline image
Bioventus Inc. (NASDAQ:BVS) Reports Mixed Q2 2025 Earnings Amid Muted Market Reaction ↗
Bioventus Inc. (BVS) reports mixed Q2 2025 results with slight revenue miss but EPS near estimates. Organic growth up 6.2%, yet stock dips 2% pre-market. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gapping stocks in Tuesday's session ↗
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million ↗
Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68. 
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
S&P 500 Gains 1%; Vimeo Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For March 11, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September ↗
 
Via Benzinga
News headline image
Solventum Stock Earns 81 RS Rating ↗
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
Via Investor's Business Daily
News headline image
Executives Buying W. P. Carey And 2 Other Stocks ↗
 
Via Benzinga
News headline image
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024 ↗
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.